z-logo
Premium
Predominant role of A 1 adenosine receptors in mediating adenosine induced vasodilatation of rat diaphragmatic arterioles: involvement of nitric oxide and the ATP‐dependent K + channels
Author(s) -
Danialou Gawiyou,
Vicaut Eric,
Sambe Abdoulaye,
Aubier Michel,
Boczkowski Jorge
Publication year - 1997
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0701247
Subject(s) - adenosine , medicine , chemistry , endocrinology , adenosine receptor , adenosine a1 receptor , cgs 21680 , agonist , vasodilation , arteriole , adenosine receptor antagonist , nitric oxide , cromakalim , microcirculation , receptor
We investigated, by intravital microscopy in rats, the role of the subtypes of adenosine receptors A 1 (A 1 /AR) and A 2 (A 2 AR) in mediating adenosine‐induced vasodilatation of second and third order arterioles of the diaphragm. Adenosine, and the A 1 AR selective agonists R (−)‐N 6 ‐(2‐phenylisopropyl)‐adenosine ( R ‐PIA) and N 6 ‐cyclo‐pentyl‐adenosine (CPA) induced a similar concentration‐dependent dilatation of diaphragmatic arterioles. The non selective A 2 AR subtype agonist N 6 ‐[2‐(3,5‐dimethoxyphenyl)‐2‐(2‐methylphenyl) ethyl]adenosine (DPMA) also dilated diaphragmatic arterioles but induced a significantly smaller dilatation than adenosine. By contrast the selective A 2a AR subtype agonist 2‐[p‐(2‐carboxyethyl)phenyl amino]‐5′‐N‐ethyl carboxamido adenosine (CGS 21680) did not modify diaphragmatic arteriolar diameter. The non selective adenosine receptor antagonist 1,3‐dipropyl‐8‐ p ‐sulphophenylxanthine (SPX, 100 μ M ) and the selective A 1 AR antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine (CPX, 50 n M ) significantly attenuated adenosine‐induced dilatation of diaphragmatic arterioles. By contrast, adenosine significantly dilated diaphragmatic arterioles in the presence of A 2 AR antagonist 3,7‐dimethyl‐1‐propargylxanthine (DMPX, 10 μ M ). The dilatation induced by adenosine was unchanged by the mast cell stabilizing agent sodium cromoglycate (cromolyn, 10 μ M ). The nitric oxide (NO) synthase inhibitor N ω ‐nitro‐ L ‐arginine ( L ‐NOARG, 300 μ M ) attenuated the dilatation induced by adenosine, and by the A 1 AR and A 2 AR agonists. The ATP‐dependent K + channel blocker glibenclamide (3 μ M ) significantly attenuated diaphragmatic arteriolar dilatation induced by adenosine and by the A 1 AR agonists R ‐PIA and CPA. By contrast, glibenclamide did not significantly modify arteriolar dilatation induced by the A 2 AR agonist DPMA. These findings suggest that adenosine‐induced dilatation of diaphragmatic arterioles in the rat is predominantly mediated by the A 1 AR, via the release of NO and activation of the ATP‐dependent K + channels.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom